CLS Presents Studies for Image-Guided Laser, Heat-Induced Cancer Immunotherapy for Tumors at ECIO 2019
Lund, Sweden – March 25, 2019 - Clinical Laserthermia Systems AB (publ) (CLS)today announced that clinical studies and results for its imILT®heat-induced cancer immunotherapy for tumors will be presented during a one hour symposium at the European Conference on Interventional Oncology (ECIO) in Amsterdam, the Netherlands this April 8-11, 2019. The company also will participate in an educational, hands-on workshop for “Tumor ablation” featuring its TRANBERG®|Thermal Therapy System